Loading
SA
Sanofi Stock: price and insider trades · India
Sanofi: what insiders have been doing
Every trade that managers of Sanofi disclose to SEBI (PIT + SAST) is tracked on this page. Between 18 October 2025 and 18 October 2026, 2 insiders published 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
With 2 filings in twelve months, the company is quieter than the median of 4 filings across the 1,986 companies we follow on the same exchange.
Over the last twelve months, not one insider purchase of Sanofi stock was filed.
Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.
Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 28 September 2026
Declarations2 total
3,500,000 shares@ ₹3,052.00100.0% of flowEquityInter-se-TransferSEBI:63ed5c651fe45f00b1842197662ddfb002abcf4a
3,500,000 shares@ ₹3,052.00100.0% of flowEquityInter-se-TransferSEBI:4dedb577bebd677d7bb0b378c74a4bcafe7b299f
2 of 2 declarations
About Sanofi
Sanofi is a global pharmaceutical company that develops medications and vaccines across various therapeutic areas. It is listed on the XBOM market.
